1.Momordicine I alleviates isoproterenol-induced cardiomyocyte hypertrophy through suppression of PLA2G6 and DGK-ζ
Hongming LI ; Yumei QIU ; Mengdie XIE ; Changsheng OUYANG ; Xiaoyun DING ; Hao ZHANG ; Wei DONG ; Yinhua XIONG ; Xilan TANG
The Korean Journal of Physiology and Pharmacology 2023;27(1):75-84
This study aimed to observe the protective effect of momordicine I, a triterpenoid compound extracted from momordica charantia L., on isoproterenol (ISO)-induced hypertrophy in rat H9c2 cardiomyocytes and investigate its potential mechanism. Treatment with 10 μM ISO induced cardiomyocyte hypertrophy as evidenced by increased cell surface area and protein content as well as pronounced upregulation of fetal genes including atrial natriuretic peptide, β-myosin heavy chain, and α-skeletal actin; however, those responses were markedly attenuated by treatment with 12.5 μg/ml momordicine I. Transcriptome experiment results showed that there were 381 and 447 differentially expressed genes expressed in comparisons of model/control and momordicine I intervention/model, respectively. GO enrichment analysis suggested that the anti-cardiomyocyte hypertrophic effect of momordicine I may be mainly associated with the regulation of metabolic processes. Based on our transcriptome experiment results as well as literature reports, we selected glycerophospholipid metabolizing enzymes group VI phospholipase A 2 (PLA2G6) and diacylglycerol kinase ζ (DGK-ζ) as targets to further explore the potential mechanism through which momordicine I inhibited ISO-induced cardiomyocyte hypertrophy.Our results demonstrated that momordicine I inhibited ISO-induced upregulations of mRNA levels and protein expressions of PLA2G6 and DGK-ζ. Collectively, momordicine I alleviated ISO-induced cardiomyocyte hypertrophy, which may be related to its inhibition of the expression of glycerophospholipid metabolizing enzymes PLA2G6 and DGK-ζ.
2.Spiritual health status and influencing factors of patients with lung cancer during perioperative period
Wei ZHENG ; Mengdie HU ; Xin HE ; Yuchen WANG ; Guimei WANG ; Yan LIU
Chinese Journal of Modern Nursing 2022;28(33):4682-4685
Objective:To explore the influencing factors by investigating the spiritual health status of patients with lung cancer during perioperative period.Methods:A total of 208 perioperative patients who underwent radical resection of lung cancer in Cancer Hospital Chinese Academy of Medical Sciences from September 2020 to September 2021 were selected as research objects by the convenient sampling method. The General Data Questionnaire, Chinese version of Functional Assessment of Chronic illness Therapy-Spiritual (FACIT-SP-12) and Family APGAR Index (APGAR) were used to investigate the patients. Pearson correlation analysis was used to explore the correlation between spiritual health and family caring. Pearson correlation analysis was used to explore the correlation between spiritual health and family caring. Multiple linear regression analysis was used to investigate the influencing factors of spiritual health in patients with lung cancer during perioperative period. A total of 208 questionnaires were sent out and 200 were effectively received, with the effective recovery of 96.15%.Results:The total score of FACIT-SP-12 of 200 patients with perioperative lung cancer was (35.59±8.16) , indicating a moderate spiritual health level. The main factors affecting spiritual health of perioperative lung cancer patients were the degree of family care, marital status and payment of medical expenses ( P<0.05) . Conclusions:The spiritual health of perioperative lung cancer patients is in the middle level, and the spiritual health of patients with different family caring degrees, marital status and medical payment method is different. Clinical medical workers can carry out targeted nursing intervention according to individual conditions of patients to improve their quality of life.
3. Clinical and cardiac magnetic resonance features of apical hypertrophic cardiomyopathy patients complicating with left ventricular apical aneurysm
Kai YANG ; Shihua ZHAO ; Minjie LU ; Yanyan SONG ; Lu LI ; Xiuyu CHEN ; Gang YIN ; Mengdie WEI
Chinese Journal of Cardiology 2019;47(7):534-538
Objective:
To evaluate the clinical and cardiac magnetic resonance (CMR) features of apical hypertrophic cardiomyopathy (ApHCM) patients complicating with left ventricular apical aneurysm (LVAA).
Methods:
CMR confirmed 25 ApHCM patients complicating with LVAA from January 2010 to December 2017 in Fuwai hospital were included in this study, and the baseline clinical data and CMR characteristics were retrospectively analyzed. There were 14 pure ApHCM (hypertrophy limited at the apical segments) complicating with LVAA patients and 11 mixed ApHCM (predominantly apical hypertrophy along with thickening of contiguous non-apical left ventricular region) with LVAA patients.
Results:
In this patient cohort,age of 84% (21/25) patients ranged between 20-70 years old, and 68% (17/25) were male. There were 68% (17/25) patients with complaint of chest distress symptom, 56% (14/25) with complaint of chest pain, 32% (8/25) with complaint of palpitation,16% (4/25) with complaint of dyspnea, and 12% (3/25) presented as syncope. ST-T segment changes of electrocardiogram were observed in all patients, and giant negative T waves were detected in 80% patients (20/25). The rate of missed diagnosis by echocardiography for detecting ApHCM and LVAA was 16% (4/25) and 68% (17/25), respectively. CMR showed discrete thin-walled dyskinetic or akinetic segment of the most distal portion of the left ventricular chamber in ApHCM patients with LVAA. Transmural late gadolinium enhancement of the aneurysmal rim was detected in 76% (19/25) patients, and the maximum transverse dimension of aneurysm was bigger in patients with transmural late gadolinium enhancement than in patients without transmural late gadolinium enhancement ((22.0±10.8)mm vs. (11.7±4.0) mm,

Result Analysis
Print
Save
E-mail